Table 4.
Univariate logistic regression analyses of WMC incidence
| Parameter | OR (95% CI) | p value |
|---|---|---|
| Postoperative NPWT (yes vs. no) | 0.19 (0.04–0.97) | 0.041 |
| Sex (female vs. male) | 0.74 (0.15–3.72) | 0.704 |
| Age (≥ 75 vs. < 75 years) | 1.72 (0.16–18.91) | 0.650 |
| BMI (≥ 30 vs. < 30 kg/m2) | 2.07 (0.33–13.18) | 0.429 |
| Smoking (yes vs. no) | 0.34 (0.03–4.68) | 0.719 |
| Radiotherapy (yes vs. no) | 1.02 (0.04–27.13) | 0.992 |
| Chemotherapy (yes vs. no) | 0.92 (0.04–23.07) | 0.926 |
| Paraostomal hernioplasty (yes vs. no) | 0.44 (0.03–5.98) | 0.532 |
| Time between previous operation (≥ 365 vs < 365 days) | 3.08 (0.23–40.65) | 0.381 |
| Cardiovascular disease (yes vs. no) | 0.67 (0.10–4.69) | 0.685 |
| Diabetes (yes vs. no) | 1.44 (0.19–11.13) | 0.719 |
| Pulmonary disease (yes vs. no) | 0.79 (0.06–10.61) | 0.858 |
| Renal disease (yes vs. no) | 3.39 (0.13–90.93) | 0.457 |
| TaTME (yes vs. no) | 1.25 (0.25–6.34) | 0.780 |
| AJCC IV (yes vs. no) | 2.19 (0.09–51.96) | 0.619 |
| Complications not related to wound management | 0.83 (0.25–2.77) | 0.762 |
Significant p-value was marked with bolded font
WMC wound management complication
NPWT negative pressure wound therapy
BMI body mass index
TaTME transanal total mesorectum excision
AJCC American Joint Committee on Cancer tumor stage